Gyorgy Baffy, MD, PhD
Adjunct Associate Professor, Medicine
Biography
Dr. Gyorgy Baffy is an Associate Professor of Medicine at Harvard Medical School, Adjunct Associate Professor of Medicine in Gastroenterology at Boston University, and Chief of Gastroenterology at the VA Boston Healthcare System. He is a graduate of the University Medical School of Debrecen in Hungary. In addition, he obtained his PhD from his studies on growth factor-mediated calcium signaling as an NIH Fogarty Fellow in the Department of Biochemistry and Biophysics at the University of Pennsylvania. He trained in gastroenterology at the University of Michigan and the Brigham and Women’s Hospital. His research interests focus on various aspects of nonalcoholic fatty liver disease such as outcomes prediction, biomarkers of lipotoxicity, metabolic reprogramming, cancer bioenergetics, and hepatocellular carcinoma. He has been involved in various clinical trials that pertain to colorectal cancer screening. He organized multiple workshops and symposia on his research topics at major US conferences. He published over 60 peer-reviewed papers and book chapters. He has participated in numerous scientific review panels and provides editorial work for several journals in gastroenterology and hepatology. In 2014, he received a Fulbright US Scholar award to teach for a semester about current issues of obesity and related disorders at the University of Debrecen. He is a Fellow of the American College of Physicians, American Gastroenterological Association, and the American Association for the Study of Liver Diseases. He is the recipient of the Madaus Prize from the Madaus Liver Foundation and the Hetényi Medal of the Hungarian Gastroenterological Association.
Other Positions
- VA Boston Healthcare System
Education
- University of Debrecen, MD
- Hungarian Academy of Sciences, PhD
Publications
- Published on 1/7/2025
Niezen S, Morgan TR, Scott D, Yakovchenko V, Patton H, Spoutz P, Yao Y, Baffy G, Fuchs M, Bajaj JS, Ekanem NR, Dominitz JA, Rogal SS. Identifying and Treating Metabolic Dysfunction-Associated Steatotic Liver Disease Among At-Risk Veterans. Am J Gastroenterol. 2025 Jan 07. PMID: 39774063.
Read at: PubMed - Published on 12/14/2024
Wong YJ, Buckholz A, Sim A, Teng M, Wong R, Curry MP, De Roza MA, Baffy G, Teoh X, Chak E, Rustagi T, Chang J, Wong GW, Tandon P, Garcia-Tsao G, Abraldes JG, Mohanty A, Fortune B. Nonalcohol-related Cirrhosis Leads to Higher 6-week Mortality After Acute Variceal Bleeding Than Alcohol-related Cirrhosis. Clin Gastroenterol Hepatol. 2024 Dec 14. PMID: 39675401.
Read at: PubMed - Published on 11/15/2024
Khalil M, Di Ciaula A, Mahdi L, Jaber N, Di Palo DM, Graziani A, Baffy G, Portincasa P. Unraveling the Role of the Human Gut Microbiome in Health and Diseases. Microorganisms. 2024 Nov 15; 12(11). PMID: 39597722.
Read at: PubMed - Published on 8/15/2024
von Rosenvinge EC, Vela SA, Paine ER, Chang MF, Hanson BJ, Taddei T, Smalley WE, Dunbar KB, Khan NH, Kahng LS, Anwar J, Zing R, Gawron A, Dominitz JA, Baffy G. A Crisis in Scope: Recruitment and Retention Challenges Reported by VA Gastroenterology Section Chiefs. Fed Pract. 2024 Aug; 41(8):256-260. PMID: 39410921.
Read at: PubMed - Published on 7/27/2024
Di Ciaula A, Khalil M, Baffy G, Portincasa P. Advances in the pathophysiology, diagnosis and management of chronic diarrhoea from bile acid malabsorption: a systematic review. Eur J Intern Med. 2024 Oct; 128:10-19. PMID: 39069430.
Read at: PubMed - Published on 6/7/2024
Baffy G, Portincasa P. Gut Microbiota and Sinusoidal Vasoregulation in MASLD: A Portal Perspective. Metabolites. 2024 Jun 07; 14(6). PMID: 38921459.
Read at: PubMed - Published on 5/22/2024
Portincasa P, Khalil M, Mahdi L, Perniola V, Idone V, Graziani A, Baffy G, Di Ciaula A. Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options. Int J Mol Sci. 2024 May 22; 25(11). PMID: 38891828.
Read at: PubMed - Published on 4/22/2024
Portincasa P, Baffy G. Metabolic dysfunction-associated steatotic liver disease: Evolution of the final terminology. Eur J Intern Med. 2024 Jun; 124:35-39. PMID: 38653634.
Read at: PubMed - Published on 4/14/2024
McCurdy H, Nobbe A, Scott D, Patton H, Morgan TR, Bajaj JS, Yakovchenko V, Merante M, Gibson S, Lamorte C, Baffy G, Ioannou GN, Taddei TH, Rozenberg-Ben-Dror K, Anwar J, Dominitz JA, Rogal SS. Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration. Dig Dis Sci. 2024 Jun; 69(6):2008-2017. PMID: 38616215.
Read at: PubMed - Published on 10/4/2023
Portincasa P, Khalil M, Graziani A, Frühbeck G, Baffy G, Garruti G, Di Ciaula A, Bonfrate L. Gut microbes in metabolic disturbances. Promising role for therapeutic manipulations? Eur J Intern Med. 2024 Jan; 119:13-30. PMID: 37802720.
Read at: PubMed
View 72 more publications: View full profile at BUMC